Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

A woman with severe angioedema improved significantly after treatment with rituximab.

Low-level laser therapy safely and effectively improves hair growth and coverage for male and female pattern hair loss.

Finasteride and analogues separated using LC-MS-MS technique.

Photobiomodulation helps hair growth safely in men and women, with laser devices working better than LED ones.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Hair transplants can make hair follicles larger and hair shafts thicker.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Finasteride helps hair growth but stopping it causes faster hair loss.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Pterostilbene significantly reduces prostate enlargement and has strong antioxidant effects.

Finasteride may reduce bleeding after TURP, but more research needed.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Men with androgenetic alopecia may have higher triglycerides, suggesting a link to lipid metabolism.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Endocrinological evaluation is crucial for properly diagnosing and treating acne.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Dutasteride is approved to help manage prostate enlargement.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Hair loss in women is often due to hereditary conditions or stress, and while treatments like minoxidil can help, diagnosis and management require medical guidance.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.